Moderating risk of Alzheimer's disease through the use of anxiolytic agents

Objectives Anxiety diagnoses occur in 17.1% in people age 65 years and older. Individuals with anxiety may be at a higher risk of the development of probable Alzheimer's disease (AD). Previous literature has suggested that anxiolytic medications may exacerbate the risk of AD development. This study explored anxiolytic medication as a potential moderator of AD risk in older adults. Methods A secondary data analysis of the National Alzheimer's...